BCHE and synovial sarcoma: Hydroxychloroquine(HCQ) is utilized for systemic Sjögren’s syndrome (SS) treatment, offering potential benefits by enhancing salivary gland function through cholinesterase activity inhibition and antigen processing interference [59–61].